Studies Say Aspirin Reduces Death Risk after Breast Cancer
A groundbreaking study by U. S. researchers has revealed that breast cancer survivors who are usually on aspirin have less chances of having the cancer return.
The study which involved more than 4,000 nurses, who were on aspirin just to avoid heart disease, had a 50% lesser risk of dying from breast cancer and a 50% lower risk that the cancer would spread.
"This is the first study to find that aspirin can significantly reduce the risk of cancer spread and death for women who have been treated for early stage breast cancer", said Dr. Michelle Holmes of Harvard Medical School, who led the study published in the Journal of Clinical Oncology.
She added that if these findings are true, then having aspirin would become a much simpler and cheap solution to help women suffering from breast cancer to live a longer and healthy life.
But she cautioned that there's no proof at the moment, so women should not start taking it just for this reason.
Holmes' team emphasized that patients should not take aspirin while undergoing radiation or chemotherapy because of the risk of side effects.
According to the experts, the results are certainly impressive and this definitely needs further probing.
New Zealand News
- Hyundai Motor Corp to create ultra-fast EV charging network E-pit in Korea
- MGE gets six-month extension for South Korea’s Inspire Entertainment Resort development project
- Price of two cheapest trims of Tesla Model 3 electric sedan increased by $500
- Genting Malaysia asks employees to accept reduced pay; executives to take leave without pay
- Tesla to design & build affordable EV in China: Tom Zhu
- Norway’s ICE car sales decline as buyers making shift to EVs
- Pursang launches Retro-inspired E-Track Motorcycle for Euro 14,449 in Netherlands
- ElectReon successfully tests dynamic wireless EV charging system on public road in Sweden
- Volvo to design special Gothenburg Green City Zone for autonomous & related technologies